← Previous Lesson Lesson Evalution: The Biosimilar Approval Process in the United States Name* First Last Email* Professional Title* Nurse Nurse Practitioner Physician Physician Assistant Pharmacist Other if you selected "other", please specify.* Specialty* Rheumatology Dermatology Other if you selected "other", please specify. EVALUATIONThis activity improved my: (check all that apply) Knowledge Competence/Skills Performance Patient Outcomes None of the above The content covered was useful and relevant to my practice*Strongly disagreeDisagreeNeutralAgreeStrongly agreeThe activity was fair, balanced, and free of commercial bias*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI am better able to: Describe the U.S. Food and Drug Administration’s approval process for biosimilars, focusing on how and why it differs from the approval process for generic and biologic drugs*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI am better able to: Discuss the importance of patient education surrounding biosimilars and the appropriate role of the nurse and advanced practice provider as patient educator as part of the shared decision making process*Strongly disagreeDisagreeNeutralAgreeStrongly agreeI would recommend this activity to others.*Strongly disagreeDisagreeNeutralAgreeStrongly agreeBased on what you learned in this activity, what will you do differently in the care of your patients?*(check all that apply) Implement new information or skill in my practice Create/revise protocols, policies, and/or procedures Seek additional information Activity validated current practice Do nothing differently—The content was not convincing Do nothing differently—System barriers prevent me from changing my practice Not applicable. I have no patient contact. Please write a short statement about what you will do differently in your practice because of what you learned.*(if no change, write “N/A”) Quizzes Status Post Test: The Biosimilar Approval Process in the United States
